Notably, IL-6/STAT3 signaling can induce a cancer stem cell phenotype: IL-6 drives the expansion of breast cancer stem-like cells by upregulating stemness factors and maintaining an undifferentiated, therapy-resistant state. Here, STAT3 is linked to cancer.